COVID-19 vaccine trials on humans began in Rome

Share this post

The Roman National Institute of Infectious Diseases named after Spallanzani began testing the coronavirus vaccine on humans. This was announced by the Italian TV channel Rai24 on July 30.

At present, laboratory trials on rodents have been successfully completed, so it was decided to start clinical trials. In total, the vaccine will be tested on 45 volunteers under 55 years of age.

The participants will be divided into three 15 people, and the vaccine will be tested on each of them one by one. If successful, the vaccine will be tested on volunteers between 65 and 75 years of age.

The vaccine is then awaiting approval by the Higher Institute of Health and the Italian Medicines Agency and the material is being tested at the ReiThera pharmaceutical company. It plans to start mass production of the product in the future.

Since the beginning of the pandemic in Italy, more than 246 thousand cases of infection with coronavirus have been recorded, 35 thousand people died. In March, the country closed for quarantine.

Earlier in July, the authorities extended the emergency regime in the country until October 15.